| Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes JH Taube, JI Herschkowitz, K Komurov, AY Zhou, S Gupta, J Yang, ... Proceedings of the National Academy of Sciences 107 (35), 15449-15454, 2010 | 1199 | 2010 |
| The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies BG Hollier, K Evans, SA Mani Journal of mammary gland biology and neoplasia 14, 29-43, 2009 | 436 | 2009 |
| Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells VL Battula, KW Evans, BG Hollier, Y Shi, FC Marini, A Ayyanan, R Wang, ... Stem cells 28 (8), 1435-1445, 2010 | 320 | 2010 |
| FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ... Cancer research 73 (6), 1981-1992, 2013 | 317 | 2013 |
| A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone L Thibaudeau, AV Taubenberger, BM Holzapfel, VM Quent, T Fuehrmann, ... Disease models & mechanisms 7 (2), 299-309, 2014 | 153 | 2014 |
| Vitronectin—Master controller or micromanager? DI Leavesley, AS Kashyap, T Croll, M Sivaramakrishnan, ... IUBMB life 65 (10), 807-818, 2013 | 138 | 2013 |
| A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer LA Selth, R Das, SL Townley, I Coutinho, AR Hanson, MM Centenera, ... Oncogene 36 (1), 24-34, 2017 | 108 | 2017 |
| Tissue factor induced by epithelial–mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells M Bourcy, M Suarez-Carmona, J Lambert, ME Francart, H Schroeder, ... Cancer research 76 (14), 4270-4282, 2016 | 98 | 2016 |
| Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration C Hyde, B Hollier, A Anderson, D Harkin, Z Upton Journal of Investigative Dermatology 122 (5), 1198-1206, 2004 | 98 | 2004 |
| Reduced Il17a expression distinguishes a Ly6cloMHCIIhi macrophage population promoting wound healing MP Rodero, SS Hodgson, B Hollier, C Combadiere, K Khosrotehrani Journal of Investigative Dermatology 133 (3), 783-792, 2013 | 96 | 2013 |
| A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome N Stylianou, ML Lehman, C Wang, AT Fard, A Rockstroh, L Fazli, ... Oncogene 38 (7), 913-934, 2019 | 94 | 2019 |
| Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis V Walia, Y Yu, D Cao, M Sun, JR McLean, BG Hollier, J Cheng, SA Mani, ... Oncogene 31 (17), 2237-2246, 2012 | 94 | 2012 |
| Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention M Nouri, E Ratther, N Stylianou, CC Nelson, BG Hollier, ED Williams Frontiers in oncology 4, 370, 2014 | 89 | 2014 |
| miR‐200/375 control epithelial plasticity‐associated alternative splicing by repressing the RNA‐binding protein Quaking KA Pillman, CA Phillips, S Roslan, J Toubia, BK Dredge, AG Bert, R Lumb, ... The EMBO journal 37 (13), e99016, 2018 | 87 | 2018 |
| Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality BWC Tse, M Volpert, E Ratther, N Stylianou, M Nouri, K McGowan, ... Oncogene 36 (24), 3417-3427, 2017 | 81 | 2017 |
| Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance M Nouri, J Caradec, AA Lubik, N Li, BG Hollier, M Takhar, ... Oncotarget 8 (12), 18949, 2017 | 71 | 2017 |
| A bioengineered 3D ovarian cancer model for the assessment of peptidase–mediated enhancement of spheroid growth and intraperitoneal spread D Loessner, SC Rizzi, KS Stok, T Fuehrmann, B Hollier, V Magdolen, ... Biomaterials 34 (30), 7389-7400, 2013 | 71 | 2013 |
| Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E … HJ Hugo, N Gunasinghe, BG Hollier, T Tanaka, T Blick, A Toh, P Hill, ... Breast Cancer Research 19, 1-25, 2017 | 64 | 2017 |
| Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth SJ Werden, N Sphyris, TR Sarkar, AN Paranjape, AM LaBaff, JH Taube, ... Oncogene 35 (46), 5977-5988, 2016 | 60 | 2016 |
| IGF2 increases de novo steroidogenesis in prostate cancer cells AA Lubik, JH Gunter, BG Hollier, S Ettinger, L Fazli, N Stylianou, ... Endocrine-related cancer 20 (2), 173-186, 2013 | 58 | 2013 |
Colleen NelsonQueensland University of TechnologyVerified email at qut.edu.au
